UBS Group’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

UBS Group’s Portfolio LVGO Stock Details LVGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-137,338	Closed	-$19.2M	–	9136
2020 Q3	$19.2M	Sell	137,338 -14,054	-9%	-$1.71M	0.01%	1193
2020 Q2	$11.4M	Buy	151,392 +133,477	+745%	+$6.99M	﹤0.01%	1408
2020 Q1	$511K	Buy	17,915 +15,735	+722%	+$407K	﹤0.01%	3944
2019 Q4	$55K	Sell	2,180 -500	-19%	-$12K	﹤0.01%	6305
2019 Q3	$47K	Buy	+2,680	New	+$81.1K	﹤0.01%	6242

UBS Group's LVGO Position: Q4 2020 in Review

UBS Group sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 137,338 shares — an estimated $19.2M sold.

UBS Group first reported a position in LVGO in Q3 2019 and held it in 5 quarters. The position peaked at $19.2M in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

UBS Group reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
UBS Group sold 137,338 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $19.2M.
UBS Group first reported a position in Livongo Health, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
UBS Group's Livongo Health, Inc. Common Stock position peaked at $19.2M in Q3 2020.
0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on UBS Group's 13F filing for Q4 2020, filed 11 Feb 2021.